Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Spironolactone 1.25mg/5ml oral suspension |
| BNF code | 0202030S0AADPDP |
| Virtual Therapeutic Moiety | Spironolactone |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Spironolactone |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 250.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Spironolactone 1.25mg/5ml oral suspension (Special Order) | |
| Virtual Medicinal Product Packs | |
| Spironolactone 1.25mg/5ml oral suspension 1 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.